Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema

By Yilmaz Taygan   Cordero-Coma Miguel   Federici Thomas J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 10, 2011-10 ,pp. : 1327-1335

Informa Healthcare

Access to resources Recommend Favorite

Enhanced permeation of triamcinolone acetonide through the buccal mucosa

By Shin S.-C.   Kim J.-Y.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 2, 2000-09 ,pp. : 217-220

Elsevier

Access to resources Recommend Favorite

Identification and characterization of triamcinolone acetonide, a microglial-activation inhibitor

By Hong Jinpyo  

Immunopharmacology and Immunotoxicology, Vol. 34, Iss. 6, 2012-12 ,pp. : 912-918

Informa Healthcare

Access to resources Recommend Favorite

Drug safety evaluation of intravitreal triamcinolone acetonide

By Veritti Daniele   Di Giulio Andrea   Sarao Valentina   Lanzetta Paolo  

Expert Opinion on Drug Safety, Vol. 11, Iss. 2, 2012-03 ,pp. : 331-340

Informa Healthcare

Access to resources Recommend Favorite

Triamcinolone acetonide: Failure to thrive and Cushing's syndrome in an infant: case report

By  

Reactions Weekly, Vol. 1, Iss. 1199, 2008-01 ,pp. : 44-45

Adis International

Access to resources Recommend Favorite